Informed consent is a foundational element of every clinical trial. Yet, the traditional paper-based process has long been ...

Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision ...

Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third ...

Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing CapacityStirling, Scotland, 30 April 2025: Symbiosis Pharmaceutical Services (Symbiosis), ...

Imagine what we could do if we could take that time and replace it with a single login to a centralized, one stop shop system ...

To meet growing demands amid an increasingly challenging industry landscape, a critical decision for a CRO is to ensure ...

Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis ...

Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fu ...

In a difficult climate for capital raisings, biotechs are turning to loans backed by their expected research and development tax refunds.

Kantata has published a case study that revealed how Suvoda, a global provider of clinical trial software solutions, switched to Kantata OX and reduced ...